A. A. Ciociola

GR 38032F (Ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man

N. J. Talley, S.F. Phillips, Andrea Paula Kafejian Haddad et al. · Digestive Diseases and Sciences · 1990 · 166 citations

Functional Gastrointestinal Disorder, Medicine, Physiology +8

Effect of selective 5HT3 antagonist (GR 38032F) on small intestinal transit and release of gastrointestinal peptides

N. J. Talley, S. F. Phillips, Andrea Paula Kafejian Haddad et al. · Digestive Diseases and Sciences · 1989 · 45 citations

Biochemistry, Gastrointestinal Pharmacology, Medicine +8

Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.

Giuseppe Fraschini, A. A. Ciociola, Leticia Esparza et al. · Journal of Clinical Oncology · 1991 · 42 citations

Oncology, Breast Cancer Patients, Medicine +12

Ranitidine, 75 mg, over‐the‐counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro‐oesophageal reflux

Susan R. Orenstein, Jeffrey L. Blumer, H. M. Faessel et al. · Alimentary Pharmacology & Therapeutics · 2002 · 41 citations · Full text

A single dose of ranitidine 150 mg modulates oesophageal acid sensitivity in patients with functional heartburn

S. Rodriguez‐Stanley, A. A. Ciociola, Sattar Zubaidi et al. · Alimentary Pharmacology & Therapeutics · 2004 · 39 citations